Cargando…
Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014–2018) Using RE-AIM
Background: Risk Evaluation and Mitigation Strategies (REMS) are safety programs that U.S. Food and Drug Administration can require to ensure a drug's benefits outweigh its risks and can be considered public health interventions. FDA's 2019 draft Guidance for Industry on REMS Assessments e...
Autores principales: | Toyserkani, Gita A., Huynh, Linda, Morrato, Elaine H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052173/ https://www.ncbi.nlm.nih.gov/pubmed/32158741 http://dx.doi.org/10.3389/fpubh.2020.00043 |
Ejemplares similares
-
Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014–2018)
por: Huynh, Linda, et al.
Publicado: (2021) -
RE-AIM in the Real World: Use of the RE-AIM Framework for Program Planning and Evaluation in Clinical and Community Settings
por: Kwan, Bethany M., et al.
Publicado: (2019) -
Planning for Implementation Success Using RE-AIM and CFIR Frameworks: A Qualitative Study
por: King, Diane K., et al.
Publicado: (2020) -
National Working Group on the RE-AIM Planning and Evaluation Framework: Goals, Resources, and Future Directions
por: Harden, Samantha M., et al.
Publicado: (2020) -
Advancing regulatory science and assessment of FDA REMS programs: A mixed-methods evaluation examining physician survey response
por: Brewer, Sarah E., et al.
Publicado: (2019)